These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18215496)

  • 1. High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction.
    Ostgathe C; Gaertner J; Nauck F; Voltz R
    J Pain Symptom Manage; 2008 Mar; 35(3):229-31. PubMed ID: 18215496
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid rotation from methadone: fraught with difficulties.
    Bhimji K
    J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of cancer pain.
    Bruera E; Fainsinger RL
    N Engl J Med; 1997 Mar; 336(13):962-3; author reply 963. PubMed ID: 9072703
    [No Abstract]   [Full Text] [Related]  

  • 6. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 7. Methadone titration: still no gauge on the tank.
    Laird BJ; Sugden CJ
    Palliat Med; 2005 Oct; 19(7):568. PubMed ID: 16295293
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone treatment.
    Rashiq S
    CMAJ; 1999 Nov; 161(10):1241. PubMed ID: 10584081
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
    Reddy S; Fisch M; Bruera E
    J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646
    [No Abstract]   [Full Text] [Related]  

  • 12. Pain management discussion forum.
    Breivik H
    J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):296-7. PubMed ID: 23909902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting comfortable with methadone.
    J Support Oncol; 2003; 1(1):52. PubMed ID: 15352643
    [No Abstract]   [Full Text] [Related]  

  • 16. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients.
    Hay JL; White JM; Bochner F; Somogyi AA
    Eur J Pain; 2008 Oct; 12(7):926-33. PubMed ID: 18262451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 20. Practicability, safety, and efficacy of a "German model" for opioid conversion to oral levo-methadone.
    Ostgathe C; Voltz R; Van Aaaken A; Klein C; Sabatowski R; Nauck F; Gaertner J
    Support Care Cancer; 2012 Sep; 20(9):2105-10. PubMed ID: 22130587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.